Treatment of Antibody Claims In the U.S. After 'Amgen v. Sanofi'
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.
Toledo Law Students File Complaint With ABA Over Legal Ethics Grading Error
"The laptop computer on which the grades were initially recorded was lost, which has made it necessary to reconstruct exam scores based on awarded points, which were recorded by Prof. Gibbons on each exam as he graded those exams," interim Dean Rebecca Zietlow wrote in an email to students last month.